Cancer has been and continues to be one the leading causes of death in many countries throughout the world. In countries such as China and India there is an ever growing and rising number of cancer patients. In China about 25% of all deaths since 2010 have been attributed to cancer. According to the International Agency for Research on Cancer the most prominent types of cancer in China are lung, colorectum, stomach, liver, and breast cancer. The prevalence rates of cancer in 2018 ranged at 18.1% for lung cancer, 12.2% for colorectum, 10.6% for stomach cancer and 9.2% for liver and 8.6% for breast cancer. As the world’s most populous country China accounts for more than 23% of new cancer rates and about 30% of cancers deaths worldwide. Due to the rising number of cancer incidents and mortality as well as the ageing population there is a high demand for highly advanced methods for cancer diagnostics and therapy. However, China is currently at a very early stage of development regarding the use of precision oncology or targeted radiotherapy. While the infrastructure has improved in recent years due to government efforts, a lack of qualified professionals and the need for procedural standardization persists. Improving the countrywide network of experts is therefore not only beneficial for companies and organizations but also enormously important from a development policy point of view.

According to the Indian Council of Medical Research and the National Cancer Registry Programme India, it is projected that at the end of 2020 there will be more than 377,830 cases of tobacco related cancers and about 427,273 of such cases in 2025.The most prevalent types of cancer amongst women are breast and cervical cancer whereas for men they are oral and lung cancer.In a study where 28 Population-based cancer registries were analyzed, it was discovered that 1 in every 7 females have a cumulative risk of contracting any type of cancer in large cities such as New Delhi whilst 1 in every 6 men have a cumulative risk of contracting any type of cancer. From these numbers we can attest to ever growing prevalence of cancer cases in both China and India.

The global disease burden from cancer extends much further than the physical and emotional toll on a patient. By building the Academy, the ICPO Foundation is determined to strengthen its commitment within the global community to provide proper training to radiochemists, medical physicists, nuclear medicine physicians, trained nurses, and patients’ advisory group. This platform focuses on developing a digital platform with virtual reality to train medical staff, identify and set up pilot centers as well as reference centers for practical trainings, awareness building on an information platform, policy consulting on both a national and international front, and capacity building of local hospitals. All of these projects will contribute to the overall objective of dissemination of modern precision oncology methods in countries such as China and India.